Trial NCT03558724

View at ClinicalTrials.gov 
Org. Study IDs: NL65856.042.18

Last trial update was posted on 2024-04-16

MeSH Interventions

Bevacizumab

MeSH Conditions

Esophageal Neoplasms

Other Conditions

Esophageal Cancer

Stopping Reasons

Dose-escalation was finished, but no clear correlation between fluorescence and tumor grade was established

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID